Complete Response of a Young Woman With MYD88^WT Bing-Neel Syndrome on Ibrutinib Monotherapy Following a Single Cycle of B Hyper-CVAD/IT MTX

Clin Lymphoma Myeloma Leuk. 2020 Nov;20(11):e809-e812. doi: 10.1016/j.clml.2020.06.004. Epub 2020 Jun 13.

Authors

Cindy M Pabon¹, Jadee L Neff², Taylor E Forns², Jie Wang³

Affiliations

¹ Department of Medicine, Duke University Medical Center, Durham, NC.
² Department of Pathology, Duke University Medical Center, Durham, NC.
³ Department of Medicine, Duke Cancer Institute, Durham, NC. Electronic address: jie.wang416@duke.edu.

PMID: 32660904
DOI: 10.1016/j.clml.2020.06.004

No abstract available

Keywords: Bruton kinase inhibitor; Lymphoplasmacytic lymphoma; Next-generation sequencing; Precision medicine; Waldenström macroglobulinemia.

Publication types

Case Reports

MeSH terms

Adenine / analogs & derivatives*
Adenine / pharmacology
Adenine / therapeutic use
Adolescent
Agammaglobulinaemia Tyrosine Kinase / antagonists & inhibitors*
Female
Humans
Myeloid Differentiation Factor 88 / drug effects*
Piperidines / pharmacology
Piperidines / therapeutic use*
Syndrome
Waldenstrom Macroglobulinemia / drug therapy*

Substances

Myeloid Differentiation Factor 88
Piperidines
ibrutinib
Agammaglobulinaemia Tyrosine Kinase
Adenine